Lendlease – Update

Lendlease has issued a profit warning indicating statutory profit after tax of $200 – $320 million, blaming the interruptions caused by the coronavirus, which have hit rents and development activity in London especially hard.

The group’s balance sheet remains strong with gearing expected to be below the bottom end of the target range of 10-20%.

Crown – Buy

The current weakness in the Crown share price could be a buying opportunity. It’s unlikely that the current COVID-related operational impacts are going to deter the interested parties who have put forward takeover offers.

Cure ETF – Buy

CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.

ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.

.

Northern Star – Buy

Northern Star Resources is under Algo Engine buy conditions and remains the only gold stock in our Algo Engine model portfolio.

If inflation is a temporary phenomenon caused by pent-up demand and supply chain issues, it is likely the 10-year yield will run into resistance and gold will soon find renewed buying interest.

Buy NST @ $10.00